Jesús Antonio Rauda-Ceja

Jesús Antonio Rauda-Ceja

Auto-generated profile, based on publicly available information

Jesús Antonio Rauda-Ceja

Ciudad Universitaria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2025 in mAbs
Verified
Journal Article
Open access
LCLuis Fernando Cofas-Vargas
Luis Fernando Cofas-Vargas
PMPaola Mendoza-Espinosa
Paola Mendoza-Espinosa
FMFernando D. Montalvo-Sandoval
Fernando D. Montalvo-Sandoval
SPSaumel Pérez-Rodriguez
Saumel Pérez-Rodriguez
JRJesús Antonio Rauda-Ceja
Jesús Antonio Rauda-Ceja
EGEnrique Garcia-Hernandez
Enrique Garcia-Hernandez
The receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein, responsible for engaging the hACE2 receptor, is the principal target of neutralizing antibodies (NAb). To better understand how viral evolution undermines NAb protection, we present a comprehensive, topology-based classification derived from 544 NAbs and 60 nanobody-RBD complex structures. Five major NAb classes, each subdivided into two subclasses, were defined by binding zone, angle of approach, hACE2 competition, and hotspot usage. A systematic mapping of NAb-antigen contacts revealed 91 recurrent hotspot residues, some of which remain fully conserved across all Omicron variants. Leveraging > 2,300 experimentally dissociation constants spanning the Wuhan strain and Omicron lineages, we conducted a comparative affinity analysis across subclasses. NAbs in classes 1-3, which overlap the receptor-binding site, show progressive loss of affinity against Omicron, with many failing to bind recent subvariants due to emergent steric clashes and limited affinity maturation against the ancestral Wuhan RBD. Nonetheless, cases of Abs exhibiting resilience to viral drift have been documented. In contrast, classes 4 and 5 maintain high affinity regardless of their initial affinity for parental strains. Contemporary in-silico epitope predictors captured only ~40% of experimentally defined hotspots, highlighting the need for structure-guided approaches. By introducing a refined topological segmentation of the RBD grounded in previously described but unsystematized regions, our classification captures a broad diversity of NAb binding modes and provides an integrative structural framework that harmonizes prior classification schemes, its relationship with circulating variants, and highlights conserved epitope features relevant to broad-spectrum vaccine and therapeutic NAb design.